Menu

Philip Mitchell has provided health regulatory counsel to a range of industry clients, including hospital systems, provider practice groups, management services organizations, clinical laboratories, managed care organizations and health insurers, pharmaceutical and biologic manufacturers, and specialty pharmacies, other proprietary and nonprofit healthcare enterprises, and investment firms.

Download full bio 

Experience

  • CinCor Pharma to Sell to AstraZeneca for Approximately $1.8 Billion 

  • Tmunity Therapeutics Agrees to Sell to Kite 

  • Horizon Therapeutics to Be Acquired by Amgen for Approximately $28 Billion 

  • Biotech Company ViaCyte to Be Acquired by Vertex Pharmaceuticals 

  • Cytokinetics – $450 Million Convertible Senior Notes Offering 

  • View all

Education

  • University of Virginia School of Law
    JD, 1986

  • Princeton University, Woodrow Wilson School
    MPA, 1987

  • The Wharton School of the University of Pennsylvania
    BS, 1982

  • University of Pennsylvania
    BA, 1982


Admissions & Credentials

New Jersey

New York

Pennsylvania

Memberships

  • American Bar Association

  • American Health Lawyers Association